Team

Mr. Gareau has 41 years of experience as a serial entrepreneur and CEO at various high-technology companies. He was also the founder and managing director of Ipax Capital, with its Ipax One Private Equity Co-Investment Fund, which was awarded “Top 10 Best Performing Buyout Fund” out of 20,500 private equity funds analyzed in the world by Preqin, a well-known London-based firm with 300 full time researchers and 14 global offices providing alternative assets data and analytics. Mr. Gareau has initiated over 32 acquisitions in eight different countries. He was granted the title of “lndividual of Extraordinary Ability” by the American​ Government in 1999.​

Thierry Pagé holds a chemical engineering degree from Polytechnique Montréal (Canada) and pursued graduate studies in applied sciences at Université de Louvain (Belgium) and in Management at MIT Sloan, Cambridge (USA). Thierry is a seasoned executive with a successful track record in entrepreneurial management, technology development, commercialization and intellectual property protection, in high-tech and health technologies. Before joining Starpax Biopharma, he held a number of senior positions, including founding CEO at Odotech Inc. and Senior Director, Sciences & Engineering at Univalor (the Technology Transfer Office for University of Montréal, its six affiliated research hospitals and Polytechnique Montréal).

Dr. Martel holds a Post-Doctorate from the Massachusetts Institute of Technology (MIT) and a Ph.D. in Electrical/Biomedical Engineering from Polytechnique Montréal. Over the years of his distinguished career, he has earned many titles, including Canada Research Chair (CRC, Government of Canada) Tier 1 in Medical Nanorobotics and the Chair of the IEEE Technical Committee on Micro-Nano-robotics and Automation. He was also a Former Lieutenant-commander and Warship Commanding Officer – Canadian Armed Forces (Navy – Reserve). Dr. Martel is responsible for scientific research at Starpax and is the inventor of the magnetic guidance, which is currently under exclusive rights to Starpax Biopharma. Dr. Martel has been published in over 100 prestigious scientific journals and magazines and has given over 200 conferences throughout the world on electromagnetism, bioengineering, nano-robotics and bio-medical engineering. Dr. Martel’s academic honours include the Queen Elizabeth II Diamond Jubilee Medal for excellence in scientific contributions and realizations; the La Presse and Radio-Canada “Personality of the Week” (twice) title; the Jean-Jacques Rousseau Prize for Interdisciplinary Research; the Top Recipient award from the National Science and Research Council of Canada; the Innovator of the Year Award (life sciences and health technology) given by Montréal InVivo; the Dr. Jean-A. Vézina Prize for Innovation and Excellence from the Société canadienne-française de radiologie (honorary member); and he was named Personality of the Month by the Fédération de l’informatique (FiQ).

Mrs. Andréanne Cyr is a CPA with over 10 years of experience in finance, accounting and administration, including holding positions as auditor and director of finance in various sectors. She studied at HEC Montréal, first completing a Bachelor’s degree in Business Administration, major in accounting, and then a Graduate Diploma in Public Accounting. She worked for several years at Grant Thornton Montréal, notably as a director on audit files for public companies, Cree communities, insurance companies as well as international audit files. She has extensive expertise in International Accounting Standards (IFRS), financial reporting, financial analysis and business process optimization.